BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.630
-0.040 (-1.50%)
At close: Mar 16, 2026, 4:00 PM EDT
2.602
-0.028 (-1.07%)
After-hours: Mar 16, 2026, 6:28 PM EDT
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $11.21 million as of March 16, 2026. Its market cap has decreased by -22.42% in one year.
Market Cap
11.21M
Enterprise Value
-2.62M
1-Year Change
-22.42%
Ranking
Category
Stock Price
$2.63
Market Cap Chart
Since July 27, 2009, BioLineRx's market cap has decreased from $33.80M to $11.21M, a decrease of -66.83%. That is a compound annual growth rate of -6.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 12.45M | -4.96% |
| Dec 31, 2025 | 13.10M | -44.21% |
| Dec 31, 2024 | 23.49M | -79.62% |
| Dec 31, 2023 | 115.26M | 305.33% |
| Dec 29, 2022 | 28.44M | -71.41% |
| Dec 30, 2021 | 99.46M | 66.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CalciMedica | 13.07M |
| Quoin Pharmaceuticals | 13.03M |
| Kairos Pharma | 12.53M |
| NewcelX | 12.49M |
| Purple Biotech | 12.42M |
| Soligenix | 12.41M |
| Curis | 12.28M |
| CytoMed Therapeutics | 12.23M |